$Amylyx Pharmaceuticals (AMLX.US)$
Can Amylyx Recover? Q4 Results Show $301.7M Loss But Pipeline Progress and Extended Cash Runway

$Amylyx Pharmaceuticals (AMLX.US)$
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals (NASDAQ: AMLX) announced that the FDA has lifted the clinical hold on its Phase 1 clinical trial of AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS treatment. The company will proceed with opening U.S. sites for screening, enrollment, and dosing.
The Phase 1 LUMINA cl...

$Amylyx Pharmaceuticals (AMLX.US)$ Amylyx Pharmaceuticals Announces FDA Lifts Clinical Hold On AMX0114 Phase 1 Clinical Trial In Treatment Of Amyotrophic Lateral Sclerosis

$Amylyx Pharmaceuticals (AMLX.US)$ lets do it again

$Amylyx Pharmaceuticals (AMLX.US)$ 🚀🌜

$Amylyx Pharmaceuticals (AMLX.US)$ yes

$Amylyx Pharmaceuticals (AMLX.US)$ am out because of earnings. will look for reentry

$Amylyx Pharmaceuticals (AMLX.US)$ waiting fir $6.4 PT

$Amylyx Pharmaceuticals (AMLX.US)$ yes let’s go

$Amylyx Pharmaceuticals (AMLX.US)$ still green